April 19, 2024 07:07 AM EDT
Pharma

Roche's Genen­tech touts la­bel ex­pan­sion for block­buster lung can­cer drug Ale­cen­sa

Katherine Lewin

News Reporter

Roche’s Genen­tech said that Ale­cen­sa scored a la­bel ex­pan­sion from the FDA, with the drug now ap­proved as an ad­ju­vant treat­ment …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Sage's roller coast­er ends in $561M ac­qui­si­tion by Su­per­nus

Sarep­ta halts Duchenne gene ther­a­py in some pa­tients af­ter sec­ond death

For­mer CEO Anne Wo­j­ci­c­ki wins bid for 23andMe

Lil­ly posts en­cour­ag­ing ear­ly-stage weight loss da­ta on amylin can­di­date

KalVista says FDA de­layed de­ci­sion on HAE drug, cit­ing ‘heavy work­load’ 

An­oth­er round of con­sol­i­da­tion is com­ing, FDA com­mis­sion­er tells staff

A service from the Financial Times